glp 1 drugs zepbound Zepbound: How It Works, How to Inject It, and Side Effects Decoding GLP-1 Weight Loss Medications

Comparative trials show that long-acting medications (exenatide once weekly, liraglutide, dulaglutide, and semaglutide) provide better glycemic control than short-acting medications (exenatide twice daily and lixisenatide) [90]

This distinction is important

Weight loss with the supplements is very slight, 1 to 4 pounds at best, White says

Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)

However, the lack of available evidence has limited researchers from making definitive conclusions on this potential association